Cargando…

Local senolysis in aged mice only partially replicates the benefits of systemic senolysis

Clearance of senescent cells (SnCs) can prevent several age-related pathologies, including bone loss. However, the local versus systemic roles of SnCs in mediating tissue dysfunction remain unclear. Thus, we developed a mouse model (p16-LOX-ATTAC) that allowed for inducible SnC elimination (senolysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farr, Joshua N., Saul, Dominik, Doolittle, Madison L., Kaur, Japneet, Rowsey, Jennifer L., Vos, Stephanie J., Froemming, Mitchell N., Lagnado, Anthony B., Zhu, Yi, Weivoda, Megan, Ikeno, Yuji, Pignolo, Robert J., Niedernhofer, Laura J., Robbins, Paul D., Jurk, Diana, Passos, João F., LeBrasseur, Nathan K., Tchkonia, Tamara, Kirkland, James L., Monroe, David G., Khosla, Sundeep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104901/ https://www.ncbi.nlm.nih.gov/pubmed/36809340 http://dx.doi.org/10.1172/JCI162519

Ejemplares similares

Targeted clearance of p21‐ but not p16‐positive senescent cells prevents radiation‐induced osteoporosis and increased marrow adiposity
por: Chandra, Abhishek, et al.
Publicado: (2022)

Efficacy and limitations of senolysis in atherosclerosis
por: Garrido, Abel Martin, et al.
Publicado: (2021)

A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues
por: Saul, Dominik, et al.
Publicado: (2022)

Senolysis induced by 25-hydroxycholesterol targets CRYAB in multiple cell types
por: Limbad, Chandani, et al.
Publicado: (2022)

Identification of a suitable endogenous control miRNA in bone aging and senescence
por: Kaur, Japneet, et al.
Publicado: (2022)

Apoptosis resistance of senescent cells is an intrinsic barrier for senolysis induced by cardiac glycosides
por: Deryabin, Pavel I., et al.
Publicado: (2021)

The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
por: Ohtani, Naoko
Publicado: (2022)

A senolysis-based theragnostic prodrug strategy towards chronic renal failure
por: Song, Yihe, et al.
Publicado: (2022)

Obesity triggers tumoral senescence and renders poorly immunogenic malignancies amenable to senolysis
por: Fournier, Frédérik, et al.
Publicado: (2022)

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers
por: Samakkarnthai, Parinya, et al.
Publicado: (2023)

Approaches towards Longevity: Reprogramming, Senolysis, and Improved Mitotic Competence as Anti-Aging Therapies
por: Melo Pereira, Sofia, et al.
Publicado: (2019)

Targeting Multiple Homeostasis-Maintaining Systems by Ionophore Nigericin Is a Novel Approach for Senolysis
por: Deryabin, Pavel I., et al.
Publicado: (2022)

Multiparametric senescent cell phenotyping reveals CD24 osteolineage cells as targets of senolytic therapy in the aged murine skeleton
por: Doolittle, Madison L., et al.
Publicado: (2023)

Multiparametric senescent cell phenotyping reveals targets of senolytic therapy in the aged murine skeleton
por: Doolittle, Madison L., et al.
Publicado: (2023)

Ouabain and chloroquine trigger senolysis of BRAF‐V600E‐induced senescent cells by targeting autophagy
por: L’Hôte, Valentin, et al.
Publicado: (2021)

MicroRNA‐19a‐3p Decreases with Age in Mice and Humans and Inhibits Osteoblast Senescence
por: Kaur, Japneet, et al.
Publicado: (2023)

A BET family protein degrader provokes senolysis by targeting NHEJ and autophagy in senescent cells
por: Wakita, Masahiro, et al.
Publicado: (2020)

A superoxide-driven redox state promotes geroconversion and resistance to senolysis in replication-stress associated senescence
por: Luo, Le, et al.
Publicado: (2023)

Modest Effects of Osteoclast‐Specific ERα Deletion after Skeletal Maturity
por: Doolittle, Madison L., et al.
Publicado: (2023)

Senolysis-Based Elimination of Chemotherapy-Induced Senescent Breast Cancer Cells by Quercetin Derivative with Blocked Hydroxy Groups
por: Lewińska, Anna, et al.
Publicado: (2022)

Protective roles of cytoplasmic p21(Cip1) (/Waf1) in senolysis and ferroptosis of lung cancer cells
por: Koyanagi, Akira, et al.
Publicado: (2022)

Preclinical studies for improving radiosensitivity of non-small cell lung cancer cell lines by combining glutaminase inhibition and senolysis
por: Fujimoto, Masaki, et al.
Publicado: (2022)

New Senolysis Approach via Antibody–Drug Conjugate Targeting of the Senescent Cell Marker Apolipoprotein D for Skin Rejuvenation
por: Takaya, Kento, et al.
Publicado: (2023)

Modulation of fracture healing by the transient accumulation of senescent cells
por: Saul, Dominik, et al.
Publicado: (2021)

Targeting cellular senescence prevents age-related bone loss in mice
por: Farr, Joshua N., et al.
Publicado: (2017)

Single‐Cell Integration of BMD GWAS Results Prioritize Candidate Genes Influencing Age‐Related Bone Loss
por: Doolittle, Madison L., et al.
Publicado: (2023)

Senolytics Improve Physical Function and Increase Lifespan in Old Age
por: Xu, Ming, et al.
Publicado: (2018)

COVID-19 and cellular senescence
por: Schmitt, Clemens A., et al.
Publicado: (2022)

A chronic wound model to investigate skin cellular senescence
por: Wyles, Saranya P., et al.
Publicado: (2023)

Cellular senescence and the skeleton: pathophysiology and therapeutic implications
por: Khosla, Sundeep, et al.
Publicado: (2022)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era
por: Verdoorn, Brandon P., et al.
Publicado: (2021)

Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice
por: Xu, Ming, et al.
Publicado: (2017)

Periodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?
por: Aquino-Martinez, Ruben, et al.
Publicado: (2020)

New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463
por: Zhu, Yi, et al.
Publicado: (2017)

Targeting senescent cells enhances adipogenesis and metabolic function in old age
por: Xu, Ming, et al.
Publicado: (2015)

Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay
por: Bergen, H. Robert, et al.
Publicado: (2015)

Senolytic drugs: from discovery to translation
por: Kirkland, J. L., et al.
Publicado: (2020)

CELLULAR SENESCENCE AS A THERAPEUTIC TARGET FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019)

Fat tissue, aging, and cellular senescence
por: Tchkonia, Tamara, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_fivtsm9shvqdbbqrins06n6o71